FI911179A0 - Behandling av oevervikt och essentiellt hoegt blodtryck samt liknande sjukdomar. - Google Patents

Behandling av oevervikt och essentiellt hoegt blodtryck samt liknande sjukdomar.

Info

Publication number
FI911179A0
FI911179A0 FI911179A FI911179A FI911179A0 FI 911179 A0 FI911179 A0 FI 911179A0 FI 911179 A FI911179 A FI 911179A FI 911179 A FI911179 A FI 911179A FI 911179 A0 FI911179 A0 FI 911179A0
Authority
FI
Finland
Prior art keywords
oevervikt
hoegt
essentiellt
blodtryck
sjukdomar
Prior art date
Application number
FI911179A
Other languages
English (en)
Finnish (fi)
Inventor
Garth J S Cooper
Brendan Leighton
Original Assignee
Amylin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Corp filed Critical Amylin Corp
Publication of FI911179A0 publication Critical patent/FI911179A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/225—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
FI911179A 1989-07-10 1991-03-08 Behandling av oevervikt och essentiellt hoegt blodtryck samt liknande sjukdomar. FI911179A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37765289A 1989-07-10 1989-07-10
PCT/US1990/003795 WO1991000737A1 (en) 1989-07-10 1990-07-10 Treatment of obesity and essential hypertension and related disorders

Publications (1)

Publication Number Publication Date
FI911179A0 true FI911179A0 (fi) 1991-03-08

Family

ID=23490003

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911179A FI911179A0 (fi) 1989-07-10 1991-03-08 Behandling av oevervikt och essentiellt hoegt blodtryck samt liknande sjukdomar.

Country Status (14)

Country Link
EP (1) EP0408294B1 (de)
JP (1) JPH04500688A (de)
AT (1) ATE128032T1 (de)
AU (1) AU620727B2 (de)
CA (1) CA2020786A1 (de)
DE (1) DE69022501T2 (de)
DK (1) DK0408294T3 (de)
ES (1) ES2080802T3 (de)
FI (1) FI911179A0 (de)
GR (1) GR3018442T3 (de)
IE (1) IE71195B1 (de)
NO (1) NO910901L (de)
NZ (1) NZ234428A (de)
WO (1) WO1991000737A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5264372A (en) * 1991-03-15 1993-11-23 Amylin Pharmaceuticals, Inc. Receptor-based screening methods for amylin agonists and antagonists
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
EP0503827A1 (de) * 1991-03-15 1992-09-16 Pfizer Inc. Verwendung von Amylin und Calcitonin-Genverwandten Peptiden und Antagonisten davon
DK0586589T3 (da) * 1991-05-24 1997-09-22 Amylin Pharmaceuticals Inc Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
CA2100745C (en) * 1991-11-19 2007-07-31 Laura S. L. Gaeta Amylin agonist peptides and uses therefor
WO1993019774A1 (en) * 1992-04-03 1993-10-14 Amylin Pharmaceuticals, Inc. Amylin and possibly insulin containing composition for the treatment of anorexia and related states
DE69333683T2 (de) * 1992-05-15 2005-10-27 Amylin Pharmaceuticals, Inc., San Diego Antikörper-testbesteck zur bestimmung von amylin
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
US5625032A (en) * 1993-07-21 1997-04-29 Amylin Pharmaceuticals, Inc. Selective amylin antagonist peptides and uses therefor
WO1996003993A2 (en) * 1994-08-05 1996-02-15 The Rockefeller University Modulation of thymocyte and t cell functional activity
US6187991B1 (en) * 1995-05-23 2001-02-13 Pfizer Inc Transgenic animal models for type II diabetes mellitus
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
WO2000078805A1 (en) * 1999-06-18 2000-12-28 Protemix Corporation Limited Peptide having preptin functionality
ES2664854T3 (es) 2005-11-14 2018-04-23 Teva Pharmaceuticals International Gmbh Anticuerpos antagonistas dirigidos contra un péptido relacionado con el gen de la calcitonina para tratar cefalea en racimos
CN101959528A (zh) 2008-03-04 2011-01-26 辉瑞有限公司 治疗慢性疼痛的方法
CA2771186C (en) 2009-08-28 2018-01-02 Rinat Neuroscience Corporation Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
EP2493919A1 (de) * 2009-10-30 2012-09-05 Novo Nordisk A/S Derivate von cgrp
TWI753471B (zh) * 2013-07-03 2022-01-21 美商艾爾德生物製藥股份有限公司 使用抗ｃｇｒｐ抗體之葡萄糖代謝的調節
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
SI3119431T1 (sl) 2014-03-21 2024-06-28 Teva Pharmaceuticals International Gmbh Antagonistična protitelesa, usmerjena proti peptidu, povezanemu z genom za kalcitonin, in postopki za uporabo le-teh
CN109952314A (zh) 2016-09-23 2019-06-28 泰瓦制药国际有限公司 治疗难治性偏头痛

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782010T2 (de) * 1986-12-04 1993-02-18 Toyo Jozo Kk Vom calcitonin-gen abgeleitete peptidderivate.
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus

Also Published As

Publication number Publication date
WO1991000737A1 (en) 1991-01-24
AU5953790A (en) 1991-02-06
EP0408294A2 (de) 1991-01-16
DE69022501T2 (de) 1996-02-01
GR3018442T3 (en) 1996-03-31
DE69022501D1 (de) 1995-10-26
AU620727B2 (en) 1992-02-20
ATE128032T1 (de) 1995-10-15
CA2020786A1 (en) 1991-01-11
DK0408294T3 (da) 1996-01-15
JPH04500688A (ja) 1992-02-06
IE71195B1 (en) 1997-02-12
EP0408294B1 (de) 1995-09-20
NO910901D0 (no) 1991-03-07
NO910901L (no) 1991-04-25
IE902514A1 (en) 1991-02-13
ES2080802T3 (es) 1996-02-16
NZ234428A (en) 1997-08-22
EP0408294A3 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
FI911179A0 (fi) Behandling av oevervikt och essentiellt hoegt blodtryck samt liknande sjukdomar.
ES2052704T3 (es) Analogos de benzodiacepina.
FI83347B (fi) Dubbelskavare i pappersmaskin och foerfarande foer reglering av denna.
FI901148A0 (fi) Tetrahydrokinolinderivat som aer anvaendbara vid vaord av neurodegenerativa stoerningar.
FI904734A0 (fi) Anordning foer maetning av tryckdifferens.
FI904735A0 (fi) Anordning foer maetning av tryckdifferens.
NO895063L (no) Fremgangsmaate for fremstilling av mineralfiberblandinger.
FI894717A (fi) Anordning foer maetning av lokalt och tidsavhaengigt upptraedande svaga biomagnetiska faelt i kroppen hos en patient.
DE68920913D1 (de) Serotonin-Antagonisten.
FR2618315B1 (fr) Dispositif de deploiement et escamotage en faux-plafond d'une literie ou similaire
FI914064A0 (fi) Foerfarande foer framstaellning av peptider med hjaelp av fastfassyntes.
FR2605037B1 (fr) Ensemble d'elements destines a l'agencement d'un lieu devant disposer alternativement d'une surface plane et d'une surface en gradins.
FI881957A (fi) Foerfarande och anordning vid en isbrytare.
NO891990D0 (no) Apparat for funksjonsproevning av sikkerhetsbelysning.
FR2660300B1 (fr) Dispositif pour la production d'ozone.
FI882868A0 (fi) Foerfarande och produkt foer paovisning av genstrukturer foer personer med stort boejelse foer att utveckla iddm.
FI864170A (fi) Foerfarande och anordning foer tillverkning av en flerskiktig extrusionsprodukt samt en med foerfarandet aostadkommen produkt.
FI895356A0 (fi) Foerfarande foer rening av roekgaser och foer aotervinning av vaerme ur roekgaser med hjaelp av ventilationsluft.
IT8920065A0 (it) Procedimento per la modificazione di emulsioni di bitume mediante elastomeri.
IT9083415A0 (it) Dispositivo di regolazione della conicita' di confezioni tessili.
FR2616313B2 (fr) Ecran pour receveur de douche ou analogue
IT8822675A0 (it) Macchina per l'applicazione automatica di cordini su flaconi.
IT8947558A0 (it) Dispositivo da tavolo per l'estrazione singola di fogli per annotazioni e simili
IT1228272B (it) Procedimento di micropellettizzazione di ceneri di pirite.
FI870910A0 (fi) Cellvaermare som anvaends foer samtidig uppvaermning av bilmotorn och bilens inre utrymmen med naetstroem samt som pausvaermare och sedvanlig bilvaermare.

Legal Events

Date Code Title Description
FD Application lapsed